Form 4: Teva Pharmaceutical Executive VP Sells Shares
SEC Form 4
Richard Daniell, Executive VP of European Commercial at Teva Pharmaceutical Industries, sold 98,943 ordinary shares on August 12, 2024.
Summary
- Richard Daniell, an Executive VP at Teva Pharmaceutical Industries, sold 98,943 ordinary shares on August 12, 2024.
- The shares were sold at a weighted average price of $17.2973.
- The prices for individual transactions ranged from $17.25 to $17.34.
- The reporting person will provide full information regarding the number of shares sold at each separate price upon request.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard SEC filing regarding an executive's share sale. It doesn't inherently indicate positive or negative news about the company.
Industry Context
This transaction is a routine disclosure of insider trading activity. It's common for executives to periodically sell shares for personal financial management.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder confidence, but is unlikely to be significant unless part of a larger trend.
Key Dates
| Date | Description |
|---|---|
| 08/12/2024 | Date of the transaction: Richard Daniell sold 98,943 ordinary shares. |
| 08/13/2024 | Date of the SEC filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.